10.30.24 -- My Kingdom For A Horse! Or At Least A CDMO

Peptide-based therapeutics are thriving, prompting advances in their manufacturing. This webinar features Cambrex experts discussing liquid-phase peptide synthesis (LPPS), peptide crystallization, and impurity analysis methods. Key topics include LPPS vs. solid-phase synthesis, scalable production workflows, advantages of crystallization, and analytical techniques like HPLC and LC-MS for purity and sequencing. Click here to learn more.

Each month, Outsourced Pharma partners with PharmSource, part of GlobalData, to deliver the “Contract Manufacturing: Opportunities and Threats (CMOT) Report.” This report highlights CDMOs potentially impacted by key events such as acquisitions, product approvals, late clinical terminations, and FDA rejections.

Delve into the concept of "Atom Economy," a principle that emphasizes optimizing the incorporation of reactants into the final product to enhance efficiency and minimize waste.

From targeting niche diseases to delivering cutting-edge medications, inhaled therapies are poised to become a cornerstone of modern medicine. Explore the intricacies of inhaled drug delivery.

Review the optimization of the manufacturing process of a pharmaceutical intermediate, and discover how yield can be improved substantially via suitable reaction engineering.

Use this resource to decide whether tablets or liquid-filled, hard-shell capsules align seamlessly with the specific requirements of an active pharmaceutical ingredient and desired trial outcomes.

Discover the benefits of flexible pilot plant equipment. Seamlessly scale up your processes, optimize your formulations, and save costs with in-house small-volume production.

Commercial Insights Officer Jamie Unwin discusses the power of innovative nanoparticle engineering technology and AI-based digital twin.

Using advanced analytical equipment and methodologies, our experts ensure each batch released is of the highest quality, assuring end-users that their medications are safe and effective.